LS Investment Advisors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
LS Investment Advisors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$214,000
+47.6%
1,912
-4.1%
0.01%
+30.0%
Q1 2020$145,000
-30.3%
1,9930.0%0.01%
-9.1%
Q4 2019$208,000
+48.6%
1,993
+41.5%
0.01%
+37.5%
Q3 2019$140,000
-13.6%
1,408
-0.7%
0.01%
-20.0%
Q2 2019$162,000
-18.2%
1,418
-10.2%
0.01%
-16.7%
Q1 2019$198,000
-9.2%
1,579
-1.7%
0.01%
-20.0%
Q4 2018$218,000
-42.0%
1,606
+17.4%
0.02%
-31.8%
Q3 2018$376,000
+17.5%
1,368
-11.3%
0.02%
+15.8%
Q2 2018$320,000
+24.5%
1,543
-0.8%
0.02%
+26.7%
Q1 2018$257,000
+20.1%
1,555
-0.6%
0.02%
+25.0%
Q4 2017$214,000
+8.6%
1,564
+7.9%
0.01%0.0%
Q3 2017$197,000
+35.9%
1,450
+21.1%
0.01%
+33.3%
Q2 2017$145,000
+14.2%
1,1970.0%0.01%
+12.5%
Q1 2017$127,000
+49.4%
1,197
+43.2%
0.01%
+33.3%
Q4 2016$85,000
+4.9%
836
+4.9%
0.01%0.0%
Q3 2016$81,000
-14.7%
7970.0%0.01%
-14.3%
Q2 2016$95,000
+23.4%
797
+10.4%
0.01%
+16.7%
Q1 2016$77,000
+4.1%
722
+6.2%
0.01%0.0%
Q4 2015$74,000
+27.6%
6800.0%0.01%
+20.0%
Q3 2015$58,000
-15.9%
6800.0%0.01%0.0%
Q2 2015$69,0006800.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders